BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Q1 2026 Earnings Call Transcript May 6, 2026
BioCryst Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-2.98 EPS, expectations were $0.06.
Operator: Good day, and welcome to the BioCryst First Quarter 2026 Earnings Conference Call. [Operator Instructions] Please note, this event is being recorded. I would now like to turn the conference over to Nick Wilder. Please go ahead.
Nick Wilder: Good morning, and welcome to...
